These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23135269)

  • 21. Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.
    Velagapudi S; Rohrer L; Poti F; Feuerborn R; Perisa D; Wang D; Panteloglou G; Potapenko A; Yalcinkaya M; Hülsmeier AJ; Hesse B; Lukasz A; Liu M; Parks JS; Christoffersen C; Stoffel M; Simoni M; Nofer JR; von Eckardstein A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):e468-e479. PubMed ID: 34407633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors.
    Waeber C; Blondeau N; Salomone S
    Drug News Perspect; 2004; 17(6):365-82. PubMed ID: 15334188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation.
    Jin F; Hagemann N; Sun L; Wu J; Doeppner TR; Dai Y; Hermann DM
    Angiogenesis; 2018 May; 21(2):381-394. PubMed ID: 29450744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor.
    Dudek SM; Camp SM; Chiang ET; Singleton PA; Usatyuk PV; Zhao Y; Natarajan V; Garcia JG
    Cell Signal; 2007 Aug; 19(8):1754-64. PubMed ID: 17475445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An engineered S1P chaperone attenuates hypertension and ischemic injury.
    Swendeman SL; Xiong Y; Cantalupo A; Yuan H; Burg N; Hisano Y; Cartier A; Liu CH; Engelbrecht E; Blaho V; Zhang Y; Yanagida K; Galvani S; Obinata H; Salmon JE; Sanchez T; Di Lorenzo A; Hla T
    Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
    Rodríguez C; González-Díez M; Badimon L; Martínez-González J
    Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
    Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D
    Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization.
    Lee MH; Appleton KM; El-Shewy HM; Sorci-Thomas MG; Thomas MJ; Lopes-Virella MF; Luttrell LM; Hammad SM; Klein RL
    J Lipid Res; 2017 Feb; 58(2):325-338. PubMed ID: 27881715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate.
    Kurano M; Hara M; Tsuneyama K; Sakoda H; Shimizu T; Tsukamoto K; Ikeda H; Yatomi Y
    Biochim Biophys Acta; 2014 Sep; 1841(9):1217-26. PubMed ID: 24814049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion.
    Sekine Y; Suzuki K; Remaley AT
    Prostate; 2011 May; 71(7):690-9. PubMed ID: 20979115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
    González-Díez M; Rodríguez C; Badimon L; Martínez-González J
    Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial S1P
    Nitzsche A; Poittevin M; Benarab A; Bonnin P; Faraco G; Uchida H; Favre J; Garcia-Bonilla L; Garcia MCL; Léger PL; Thérond P; Mathivet T; Autret G; Baudrie V; Couty L; Kono M; Chevallier A; Niazi H; Tharaux PL; Chun J; Schwab SR; Eichmann A; Tavitian B; Proia RL; Charriaut-Marlangue C; Sanchez T; Kubis N; Henrion D; Iadecola C; Hla T; Camerer E
    Circ Res; 2021 Feb; 128(3):363-382. PubMed ID: 33301355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
    Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
    Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
    J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal HDL Counteracts Placental Vascular Inflammation via S1P-S1PR1 Axis.
    Del Gaudio I; Hendrix S; Christoffersen C; Wadsack C
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine-1-phosphate receptor-2 mediated NFκB activation contributes to tumor necrosis factor-α induced VCAM-1 and ICAM-1 expression in endothelial cells.
    Zhang W; An J; Jawadi H; Siow DL; Lee JF; Zhao J; Gartung A; Maddipati KR; Honn KV; Wattenberg BW; Lee MJ
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():62-71. PubMed ID: 23770055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate.
    Dueñas AI; Aceves M; Fernández-Pisonero I; Gómez C; Orduña A; Crespo MS; García-Rodríguez C
    Cardiovasc Res; 2008 Aug; 79(3):537-44. PubMed ID: 18411230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARγ agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca(2+)]i increases in renal mesangial cells.
    Koch A; Völzke A; Puff B; Blankenbach K; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
    Biochim Biophys Acta; 2013 Nov; 1831(11):1634-43. PubMed ID: 23906789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis.
    Del Galdo S; Vettel C; Heringdorf DM; Wieland T
    Cell Signal; 2013 Dec; 25(12):2478-84. PubMed ID: 23993968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sphingosine-1-phosphate receptor 2 mediates endothelial cells dysfunction by PI3K-Akt pathway under high glucose condition.
    Liu W; Liu B; Liu S; Zhang J; Lin S
    Eur J Pharmacol; 2016 Apr; 776():19-25. PubMed ID: 26921757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.